BioStem Technologies (BSEM) Subsidiary Nesvik Pharmaceuticals Announces the Completion of An Asset Purchase of Multiple New Drug Compounds and Launches Joint Development Venture with CCM Pharma Solutions
July 19, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 19, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals (f/k/a BioStem Pharmaceuticals), a subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”),...
BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients
June 18, 2018 17:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies, Inc. Launches SEO Optimized Website and Facility Expansion to Include Schedule III-V DEA Product Storage
November 07, 2017 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Nov. 07, 2017 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (the “Company”) announced today that, Qualified Pharma Ingredients, Inc. (QPI), an Active...
Emulex HBAs and CNAs Optimized for New Intel(r) Xeon(r) Processor 5500 Series Platforms
March 30, 2009 15:00 ET
|
Emulex Corporation
COSTA MESA, Calif., March 30, 2009 (GLOBE NEWSWIRE) -- Emulex Corporation (NYSE:ELX) today announced that its LightPulse(r) Host Bus Adapters (HBAs) and OneConnect(tm) Universal Converged Network...